{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atomoxetine+Hydrochloride", "query": { "intervention": "Atomoxetine Hydrochloride" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 128, "total_pages": 13, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atomoxetine+Hydrochloride&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T09:18:50.623Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06566820", "title": "Continuation Protocol for Obstructive Sleep Apnea (OSA)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "OSA" ], "interventions": [ { "name": "Aroxybutynin and Atomoxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Apnimed", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1280, "start_date": "2024-07-03", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-05-13", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 93, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Chandler, Arizona + 80 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06566820" }, { "nct_id": "NCT00304161", "title": "Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depressive Disorder", "Parkinson Disease" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "30 Years to 79 Years" }, "enrollment_count": 55, "start_date": "2004-07", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2017-01-30", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00304161" }, { "nct_id": "NCT00566371", "title": "The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Hyperactivity Disorder", "Insomnia" ], "interventions": [ { "name": "atomoxetine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rhode Island Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 36, "start_date": "2005-06", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2010-08-16", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT00566371" }, { "nct_id": "NCT02191358", "title": "YouScript IMPACT Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adverse Drug Events", "Adverse Drug Reactions", "Drug Interaction Potentiation", "Drug Metabolism, Poor, CYP2D6-RELATED", "Drug Metabolism, Poor, CYP2C19-RELATED", "Cytochrome P450 Enzyme Deficiency", "Cytochrome P450 CYP2D6 Enzyme Deficiency", "Cytochrome P450 CYP2C9 Enzyme Deficiency", "Cytochrome P450 CYP2C19 Enzyme Deficiency", "Cytochrome P450 CYP3A Enzyme Deficiency", "Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant", "Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant", "Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant" ], "interventions": [], "intervention_types": [], "sponsor": "Genelex Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 800, "start_date": "2014-10", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2017-03-01", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 7, "location_summary": "Garden Grove, California • Denver, Colorado • Lexington, Kentucky + 3 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Towson", "state": "Maryland" }, { "city": "Fall River", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02191358" }, { "nct_id": "NCT05933603", "title": "Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obstructive Sleep Apnea", "Down Syndrome" ], "interventions": [ { "name": "Atomoxetine and Oxybutynin (ato-oxy)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 36, "start_date": "2023-09-29", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05933603" }, { "nct_id": "NCT00844753", "title": "Atomoxetine, Placebo and Parent Management Training in Autism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Autism", "Pervasive Development Disorder", "Asperger's Disorder", "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Parent Management Training", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "14 Years", "sex": "ALL", "summary": "5 Years to 14 Years" }, "enrollment_count": 128, "start_date": "2008-10", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2016-02-04", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 3, "location_summary": "Rochester, New York • Columbus, Ohio • Pittsburgh, Pennsylvania", "locations": [ { "city": "Rochester", "state": "New York" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00844753" }, { "nct_id": "NCT02046551", "title": "Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Nicotine Dependence" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 0, "start_date": "2014-04", "completion_date": "2017-02", "has_results": false, "last_update_posted_date": "2017-05-22", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02046551" }, { "nct_id": "NCT00223691", "title": "Treatment of Orthostatic Hypotension in Autonomic Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Failure", "Orthostatic Hypotension" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Pyridostigmine Bromide", "type": "DRUG" }, { "name": "Yohimbine", "type": "DRUG" }, { "name": "Midodrine HCl", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "water intake", "type": "OTHER" }, { "name": "Diphenhydramine Hydrochloride", "type": "DRUG" }, { "name": "Ranitidine HCL", "type": "DRUG" }, { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Ergotamine/ Caffeine", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pseudoephedrine", "type": "DRUG" }, { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxymetazoline 0.05% nasal solution", "type": "DRUG" }, { "name": "Bovril", "type": "DIETARY_SUPPLEMENT" }, { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Rivastigmine tartrate", "type": "DRUG" }, { "name": "Carbidopa/levodopa", "type": "DRUG" }, { "name": "Inflatable abdominal binder", "type": "DEVICE" }, { "name": "inflatable abdominal binder (sham)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 389, "start_date": "2002-03", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00223691" }, { "nct_id": "NCT01133847", "title": "Interventions for Children With Attention and Reading Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Hyperactivity Disorder", "Reading Disabilities" ], "interventions": [ { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Intensive reading instruction", "type": "BEHAVIORAL" }, { "name": "Parent Training", "type": "BEHAVIORAL" }, { "name": "Mixed Salt Amphetamine", "type": "DRUG" }, { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Guanfacine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "7 Years to 12 Years" }, "enrollment_count": 222, "start_date": "2010-11", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2017-04-11", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 2, "location_summary": "Cincinnati, Ohio • Houston, Texas", "locations": [ { "city": "Cincinnati", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01133847" }, { "nct_id": "NCT00702364", "title": "Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Brain INjury" ], "interventions": [ { "name": "atomoxetine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Craig Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2008-01", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2014-09-15", "last_synced_at": "2026-09-26T09:18:50.623Z", "location_count": 1, "location_summary": "Englewood, Colorado", "locations": [ { "city": "Englewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00702364" } ] }